Prof Dr. Mehlika Dilek Altıntop | Medicinal Chemistry | Women Researcher Award

Prof Dr. Anadolu University, Turkey

Dr. Mehlika Dilek Altıntop is a prominent Professor in Pharmaceutical Chemistry at Anadolu University. Her academic journey includes a Bachelor’s from Anadolu University, followed by a Master’s and Ph.D. in Pharmaceutical Chemistry from the same institution. She has served in various academic roles, including Research Assistant, Assistant Professor, and currently as a Professor. Her administrative roles include serving as Associate Director and Quality Coordinator at Anadolu University. Dr. Altıntop has received numerous awards for her research, including the Outstanding Woman Researcher Award and multiple Article Performance Awards. She is actively involved in editorial and guest editing roles in prestigious scientific journals and has supervised numerous master’s and doctoral dissertations in her field.

Professional profile

Scopus

Education 📚

Primary School: İkieylül Elementary School (1991-1996)Secondary School – High School: Eskişehir Anatolian High School (1996-2003)Undergraduate: Anadolu University, Faculty of Pharmacy (2003-2007)Master’s Degree (with Thesis): Anadolu University, Graduate School of Health Sciences, Department of Pharmaceutical Chemistry (2007-2009)Doctoral Degree: Anadolu University, Graduate School of Health Sciences, Department of Pharmaceutical Chemistry (2009-2012)Languages: English (Excellent)

Academic Titles 🎓

Research Assistant: Anadolu University, Faculty of Pharmacy (2010-2012)Research Assistant Doctor: Anadolu University, Faculty of Pharmacy (2012-2014)Assistant Professor Doctor: Anadolu University, Faculty of Pharmacy (2014-2015)Associate Professor Doctor: Anadolu University, Faculty of Pharmacy (2015-2020)Professor Doctor: Anadolu University, Faculty of Pharmacy (2020-Present)Administrative Roles 🏛️Erasmus/Farabi/Mevlana Assistant Coordinator: Anadolu University Faculty of Pharmacy (2013-2014)Associate Director: Anadolu University Graduate School of Health Sciences (2014-2017, 2023)Quality Coordinator: Anadolu University Graduate School of Health Sciences (2022-2023)

Awards and Honors 🏆

Anadolu University Faculty of Pharmacy Championship Award (2007)The Scientific and Technological Research Council of Turkey Graduate Scholarship (2007-2009)Anadolu University Science and Technology Encouragement Award (2014)Anadolu University Gold & Platinum Article Performance Awards (2015)Outstanding Reviewer, European Journal of Medicinal Chemistry (2016)Turkish Pharmacists’ Association Academy of Pharmacy Encouragement Award (2019)ISIF’21 Silver Medal for “Targeted Novel Triazolothiadiazine Derivatives for The Treatment of Lung Cancer” (2021)Award of Outstanding Woman Researcher in Pharmaceutical Chemistry, VIWA 2021

Publication📜

 

Design, Synthesis, and In Vivo Evaluation of a New Series of Indole-Chalcone Hybrids as Analgesic and Anti-Inflammatory Agents
Authors: Baramaki, I., Altıntop, M.D., Arslan, R., Hasan, A., Bektaş Türkmen, N.
Journal: ACS Omega, 2024, 9(10), pp. 12175–12183

Design, Synthesis, and Evaluation of a New Series of 2-Pyrazolines as Potential Antileukemic Agents
Authors: Altıntop, M.D., Cantürk, Z., Özdemir, A.
Journal: ACS Omega, 2023, 8(45), pp. 42867–42877

Design, Synthesis, and Evaluation of a New Series of Hydrazones as Small-Molecule Akt Inhibitors for NSCLC Therapy
Authors: Erdönmez, B., Altıntop, M.D., Akalın Çiftçi, G., Özdemir, A., Ece, A.
Journal: ACS Omega, 2023, 8(22), pp. 20056–20065

A New Series of Hydrazones as Small-Molecule Aldose Reductase Inhibitors
Authors: Altıntop, M.D., Demir, Y., Türkeş, C., Beydemir, Ş., Özdemir, A.
Journal: Archiv der Pharmazie, 2023, 356(4), 2200570

A New Series of Thiazole-Hydrazone Hybrids for Akt-Targeted Therapy of Non-Small Cell Lung Cancer
Authors: Orujova, T., Ece, A., Akalın Çiftçi, G., Özdemir, A., Altıntop, M.D.
Journal: Drug Development Research, 2023, 84(2), pp. 185–199

Synthesis, In Silico and In Vitro Evaluation of New 3,5-Disubstituted-1,2,4-Oxadiazole Derivatives as Carbonic Anhydrase Inhibitors and Cytotoxic Agents
Authors: Kucukoglu, K., Faydali, N., Bul, D., Ozturk, B., Guzel, I.
Journal: Journal of Molecular Structure, 2023, 1276, 134699

Discovery of Small Molecule COX-1 and Akt Inhibitors as Anti-NSCLC Agents Endowed with Anti-Inflammatory Action
Authors: Altıntop, M.D., Akalın Çiftçi, G., Yılmaz Savaş, N., Alataş, Ö., Özdemir, A.
Journal: International Journal of Molecular Sciences, 2023, 24(3), 2648

Microwave-Assisted Synthesis of a Series of 4,5-Dihydro-1H-Pyrazoles Endowed with Selective COX-1 Inhibitory Potency
Authors: Altıntop, M.D., Temel, H.E., Özdemir, A.
Journal: Journal of the Serbian Chemical Society, 2023, 88(4), pp. 355–365

Design, Synthesis, and Biological Evaluation of a New Series of Arylidene Indanones as Small Molecules for Targeted Therapy of Non-Small Cell Lung Carcinoma and Prostate Cancer
Authors: Altıntop, M.D., Özdemir, A., Temel, H.E., Kaplancıklı, Z.A., Akalın Çiftçi, G.
Journal: European Journal of Medicinal Chemistry, 2022, 244, 114851

A New Series of Thiosemicarbazone-Based Anti-Inflammatory Agents Exerting Their Action Through Cyclooxygenase Inhibition
Authors: Altıntop, M.D., Sever, B., Akalın Çiftçi, G., Alataş, Ö., Özdemir, A.
Journal: Archiv der Pharmazie, 2022, 355(9), 2200136

Prof Dr. Mehlika Dilek Altıntop | Medicinal Chemistry | Women Researcher Award

You May Also Like